South San Francisco, CA, United States of America

Jakob Fuhrmann

This inventor holds 1 USPTO granted patent and 5 published patent applications and 3 EPO patents. Top assignee: Genentech, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jakob Fuhrmann. Retrieved from https://idiyas.com/inventor/jakob-fuhrmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jakob Fuhrmann

Introduction

Jakob Fuhrmann is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of macrocyclic compounds, showcasing his expertise and innovative spirit. His work has led to the development of valuable compounds with various applications.

Latest Patents

Jakob Fuhrmann holds a patent for "Macrocyclic compounds and methods of use thereof." This patent highlights his focus on macrocyclic compounds, which are essential in various scientific and industrial applications. He has 1 patent to his name, reflecting his dedication to advancing knowledge in his field.

Career Highlights

Fuhrmann is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His role at Genentech allows him to collaborate with other talented professionals and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Wayne J Fairbrother and Hao Wu. Their collaboration fosters a dynamic environment that encourages creativity and innovation in their projects.

Conclusion

Jakob Fuhrmann's contributions to the field of macrocyclic compounds exemplify his commitment to innovation and scientific advancement. His work at Genentech, along with his collaborations, positions him as a key figure in the biotechnology industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…